APTOFAptose Biosciences Inc.vs its industry peers
A metric-by-metric comparison of Aptose Biosciences Inc. against Biological Products, (No Diagnostic Substances) — valuation, growth, profitability, quality and total return, with each figure's rank within the peer group. Every value is Go-computed from SEC filings and delayed prices; ranks are sorted positions within the group only — descriptive, not advice.
| Company | Market cap | P/E (TTM) | P/B | P/S | Revenue growth (YoY) | Earnings growth (YoY) | EBIT margin | ROE | ROIC | Piotroski F | 1y total return | Dividend yield |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| APTOFThis | — | — | — | — | — | -0.1%#10 | — | — | — | — | — | — |
| ABPO | — | — | — | — | 50.0%#5 | 60.0%#4 | -4618.6%#7 | — | — | — | — | — |
| ADAPY | — | — | — | — | 195.3%#3 | 37.8%#6 | -38.6%#5 | — | — | — | — | — |
| AGMB | $483M#5 | — | — | — | — | — | — | — | — | — | — | — |
| AGTX | — | — | — | — | -100.0%#9 | 14.4%#8 | — | — | — | — | — | — |
| ALVO | $1.2B#3 | — | — | 2.0x#2 | 19.7%#6 | 112.0%#2 | 13.3%#3 | — | — | — | -55.1%#5 | — |
| ALVOW | $100M#7 | — | — | 0.2x#1 | 19.7%#6 | 112.0%#2 | 13.3%#3 | — | — | — | -74.6%#6 | — |
| APTN | — | — | — | — | — | -65.5%#12 | — | — | — | — | — | — |
| ARGX | $53.5B#1 | — | — | 1506.5x#5 | 254.4%#2 | 55.1%#5 | 2965.7%#1 | — | — | — | 29.2%#2 | — |
| AUTL | $562M#4 | — | 5.2x#2 | 7.4x#4 | 644.9%#1 | -30.3%#11 | -358.9%#6 | -264.2%#2 | — | — | -10.2%#3 | — |
| BNTX | $23.5B#2 | — | — | — | — | — | — | — | — | — | -15.9%#4 | — |
| CGEN | $228M#6 | 6.3x#1 | 2.2x#1 | 3.1x#3 | 161.1%#4 | 348.4%#1 | 43.1%#2 | 34.4%#1 | — | — | 65.1%#1 | — |
| CKDXF | — | — | — | — | -80.0%#8 | 26.1%#7 | -623048.0%#9 | — | — | — | — | — |
| CLDWW | — | — | — | — | — | 10.1%#9 | -44977.8%#8 | -403.4%#3 | — | — | — | — |
Peer set: US filers sharing this company's SEC industry classification (SIC 2836). SIC is coarse — conglomerates and multi-segment companies map imperfectly. Values from SEC filings + delayed prices; ranks are within-group positions only. Market cap, P/E, P/B, P/S, 1y total return and dividend yield are computed from each member's latest snapshot price when the table is built (see as-of; snapshot prices can lag) — not live. Table built 2026-08-09.
Source: SEC XBRL filings + delayed prices · ranks are within-group positions · For reference only · Not investment advice